BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 31064417)

  • 1. UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells.
    Niinuma T; Kitajima H; Kai M; Yamamoto E; Yorozu A; Ishiguro K; Sasaki H; Sudo G; Toyota M; Hatahira T; Maruyama R; Tokino T; Nakase H; Sugai T; Suzuki H
    Clin Epigenetics; 2019 May; 11(1):70. PubMed ID: 31064417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties.
    Kong X; Chen J; Xie W; Brown SM; Cai Y; Wu K; Fan D; Nie Y; Yegnasubramanian S; Tiedemann RL; Tao Y; Chiu Yen RW; Topper MJ; Zahnow CA; Easwaran H; Rothbart SB; Xia L; Baylin SB
    Cancer Cell; 2019 Apr; 35(4):633-648.e7. PubMed ID: 30956060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UHRF1 Induces Methylation of the
    Kim MJ; Lee HJ; Choi MY; Kang SS; Kim YS; Shin JK; Choi WS
    Mol Cells; 2021 Mar; 44(3):146-159. PubMed ID: 33795533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress-mediated apoptosis.
    Kim JK; Kan G; Mao Y; Wu Z; Tan X; He H; Lee C
    Mol Oncol; 2020 Feb; 14(2):329-346. PubMed ID: 31782885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic repression of regulator of G-protein signaling 2 by ubiquitin-like with PHD and ring-finger domain 1 promotes bladder cancer progression.
    Ying L; Lin J; Qiu F; Cao M; Chen H; Liu Z; Huang Y
    FEBS J; 2015 Jan; 282(1):174-82. PubMed ID: 25323766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation.
    Zhou L; Shang Y; Jin Z; Zhang W; Lv C; Zhao X; Liu Y; Li N; Liang J
    Cancer Biol Ther; 2015; 16(8):1241-51. PubMed ID: 26147747
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Hu B; Xian Z; Zou Q; Zhang D; Su D; Yao J; Ren D
    Cancer Biother Radiopharm; 2021 Feb; 36(1):45-57. PubMed ID: 32379550
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical significance and biological role of KLF17 as a tumour suppressor in colorectal cancer.
    Jiang X; Shen TY; Lu H; Shi C; Liu Z; Qin H; Wang F
    Oncol Rep; 2019 Nov; 42(5):2117-2129. PubMed ID: 31545467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.
    Babbio F; Pistore C; Curti L; Castiglioni I; Kunderfranco P; Brino L; Oudet P; Seiler R; Thalman GN; Roggero E; Sarti M; Pinton S; Mello-Grand M; Chiorino G; Catapano CV; Carbone GM; Bonapace IM
    Oncogene; 2012 Nov; 31(46):4878-87. PubMed ID: 22330138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-202 inhibits the proliferation and invasion of colorectal cancer by targeting UHRF1.
    Lin Y; Chen Z; Lin S; Zheng Y; Liu Y; Gao J; Chen S
    Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):598-606. PubMed ID: 31058289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression.
    Sabatino L; Fucci A; Pancione M; Carafa V; Nebbioso A; Pistore C; Babbio F; Votino C; Laudanna C; Ceccarelli M; Altucci L; Bonapace IM; Colantuoni V
    Oncogene; 2012 Dec; 31(49):5061-72. PubMed ID: 22286757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of
    Beck A; Trippel F; Wagner A; Joppien S; Felle M; Vokuhl C; Schwarzmayr T; Strom TM; von Schweinitz D; Längst G; Kappler R
    Clin Epigenetics; 2018; 10():27. PubMed ID: 29507645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of UHRF1 by microRNA-9 modulates colorectal cancer cell proliferation and apoptosis.
    Zhu M; Xu Y; Ge M; Gui Z; Yan F
    Cancer Sci; 2015 Jul; 106(7):833-9. PubMed ID: 25940709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells.
    Kai M; Niinuma T; Kitajima H; Yamamoto E; Harada T; Aoki H; Maruyama R; Toyota M; Sasaki Y; Sugai T; Tokino T; Nakase H; Suzuki H
    PLoS One; 2016; 11(12):e0168281. PubMed ID: 27977763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
    Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
    Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of UHRF1 in methylation regulation and angiogenesis].
    Guo Z; Mo Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Feb; 37(2):200-204. PubMed ID: 32034755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous silencing Aurora-A and UHRF1 inhibits colorectal cancer cell growth through regulating expression of DNMT1 and STAT1.
    Han J; Chen X; Xu J; Chu L; Li R; Sun N; Jiang Z; Liu H; Ge X; Zheng J; Yang J; Ikezoe T
    Int J Med Sci; 2021; 18(15):3437-3451. PubMed ID: 34522170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The finger loop of the SRA domain in the E3 ligase UHRF1 is a regulator of ubiquitin targeting and is required for the maintenance of DNA methylation.
    Vaughan RM; Rothbart SB; Dickson BM
    J Biol Chem; 2019 Oct; 294(43):15724-15732. PubMed ID: 31481468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone and non-histone methyllysine reader activities of the UHRF1 tandem Tudor domain are dispensable for the propagation of aberrant DNA methylation patterning in cancer cells.
    Vaughan RM; Kupai A; Foley CA; Sagum CA; Tibben BM; Eden HE; Tiedemann RL; Berryhill CA; Patel V; Shaw KM; Krajewski K; Strahl BD; Bedford MT; Frye SV; Dickson BM; Rothbart SB
    Epigenetics Chromatin; 2020 Oct; 13(1):44. PubMed ID: 33097091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional dissection of the role of UHRF1 in the regulation of retinoblastoma methylome.
    Kan G; He H; Zhao Q; Li X; Li M; Yang H; Kim JK
    Oncotarget; 2017 Jun; 8(24):39497-39511. PubMed ID: 28467809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.